This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Laboratoire Medidom Sa, Chemedica S.a., Laboratorie Medidom S.a.. Active years: 1997-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2008
Title: The Innovative Contributions of Guido Di Napoli
Introduction
Guido Di Napoli is a notable inventor based in Collonge-Bellerive, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of processes for pharmaceutical compounds. With a total of eight patents to his name, Di Napoli's work has had a meaningful impact on the industry.
Latest Patents
One of his latest patents is a process for preparing aloe-emodin. This process involves oxidizing aloin by treatment with an oxygen-containing gas in the presence of an acid. The aloe-emodin produced can be further utilized for the production of rhein and diacerein. This is achieved by oxidizing aloe-emodin with a chromium-free oxidizing medium to obtain rhein, which can then be purified and acetylated to yield diacerein. Another significant patent is for ophthalmic formulations, which describes a topical ophthalmic formulation in the form of an aqueous solution. This formulation comprises cyclosporin, hyaluronic acid or one of its salts, and polysorbate 80.
Career Highlights
Throughout his career, Guido Di Napoli has worked with various companies, including Laboratoire Medidom SA and Laboratoire Medidom S.A. His expertise in the field has allowed him to develop innovative solutions that address specific needs in pharmaceutical applications.
Collaborations
One of his notable collaborators is Stefano Carlino. Their partnership has contributed to the advancement of research and development in their respective fields.
Conclusion
Guido Di Napoli's innovative work and patents reflect his dedication to advancing pharmaceutical chemistry. His contributions continue to influence the industry and pave the way for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile